ALX40-4C [769]



ALX40-4C


SMILES CC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
InChIKey LGLVVVCSQBZONM-HCCLCSBVSA-N
Sequence RRRRRRRRR
HELM PEPTIDE1{[ac].[dR].[dR].[dR].[dR].[dR].[dR].[dR].[dR].[dR].[am]}$$$$

Chemical Properties

Hydrogen bond acceptors 19
Hydrogen bond donors 37
Rotatable bonds 54
Log P -11.776
Molecular weight (Da) 1463.9
Stereochemistry info unspecified

Database connections

Model (AF2) apelin CXCR4
Ligand site mutations CXCR4

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

ALX40-4C


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) apelin CXCR4
Ligand site mutations CXCR4

Compound is not listed as a drug.